Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and Fibrosis
肺泡稳态、损伤、再生和纤维化的机制
基本信息
- 批准号:10571931
- 负责人:
- 金额:$ 89.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2029-02-28
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute Respiratory Distress SyndromeAlveolarAlveolar CellAlveolar MacrophagesAlveolusAutomobile DrivingCellsChronicChronic lung diseaseClinicalCollaborationsDedicationsDefectDevelopmentDiseaseEpithelial Cell ProliferationEpithelial CellsFibroblastsFibrosisFundingHealthHomeostasisHumanImpairmentInjuryInvestigationKnowledgeLung diseasesMentorshipMissionMolecularMorbidity - disease rateMusNatural regenerationNatureOrganismPathogenesisPathologicPermeabilityPhysiologicalProcessPulmonary FibrosisRecoveryServicesTimeTransitional CellUnited States National Institutes of HealthWorkalveolar epitheliumalveolar homeostasiseffective therapyepithelial injuryepithelium regenerationidiopathic pulmonary fibrosisknockout genelung injurymortalitymouse modelnovelnovel therapeuticsprogenitorregenerative
项目摘要
PROJECT SUMMARY
Acute and chronic parenchymal lung diseases, such as the acute respiratory distress syndrome (ARDS) and
idiopathic pulmonary fibrosis (IPF), are associated with significant morbidity and mortality. Therapies are limited,
largely due to our incomplete understanding of disease pathogenesis. These diseases arise from injury to the
alveolar epithelium with ineffectual regeneration. In accordance with the NIH mission to “seek fundamental
knowledge about the nature…of living systems and apply that knowledge to enhance health”, we aim to identify
mechanisms by which alveolar homeostasis is maintained, disrupted during injury, and restored during
physiologic regeneration and how these processes go awry in the pathogenesis of ARDS and IPF.
The normal alveolus consists of alveolar type 2 epithelial cells (AEC2s) and AEC1s, which form a tight barrier,
with quiescent fibroblasts and alveolar macrophages. The molecular mechanisms of cell-cell crosstalk that
maintain alveolar quiescence during homeostasis are poorly understood. During lung injury, AECs die. Severe
acute injury results in barrier permeability, leading to ARDS; clinical recovery requires epithelial regeneration. In
IPF, repetitive epithelial injury with impaired regeneration begets fibrosis. However, the mechanisms underlying
physiologic regeneration and how it is impaired in the pathogenesis of IPF are incompletely understood.
AEC2s are the primary progenitor responsible for physiologic alveolar regeneration. AEC2s proliferate, then
differentiate into AEC1s. We and others have identified mechanisms of AEC2 proliferation. Moreover, we were
the first to identify a novel transitional cell state transiently assumed by regenerating AEC2s before differentiating
into AEC1s. We also found that transitional cells persist in pulmonary fibrosis, suggesting that persistence of
transitional cells may be the critical regenerative defect driving fibrosis. However, the mechanisms that induce
AEC2s to assume the transitional state and transitional cells to differentiate into AEC1s during physiologic
regeneration and by which transitional cells persist and promote fibrosis in IPF are unknown.
Here, we will explore the mechanisms of alveolar cell-cell crosstalk that maintain homeostasis and promote
physiologic regeneration and how these mechanisms go awry in ARDS and fibrosis. We will use lineage tracing
combined with AEC2-specific inducible gene knockout in mouse models of homeostasis, injury, physiologic
regeneration, and fibrosis. Cultured human and murine AECs will be used to dissect mechanism. The proposed
work will fill fundamental gaps in our understanding of alveolar homeostasis and physiologic and
pathologic regeneration and overcome critical barriers to the development of novel therapies for ARDS
and IPF. The funding will also support the pursuit of new lines of investigation and the dedication of appropriate
time and energy into collaborations, professional service, and mentorship.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Rachel Lynne Zemans其他文献
Rachel Lynne Zemans的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Rachel Lynne Zemans', 18)}}的其他基金
Mechanisms of Alveolar Homeostasis, Injury, Regeneration, and Fibrosis
肺泡稳态、损伤、再生和纤维化的机制
- 批准号:
10348551 - 财政年份:2022
- 资助金额:
$ 89.84万 - 项目类别:
Role of TGFβ/BMP Antagonism in Regeneration of the Alveolar Epithelium After Lung Injury
TGFβ/BMP 拮抗作用在肺损伤后肺泡上皮再生中的作用
- 批准号:
10165810 - 财政年份:2020
- 资助金额:
$ 89.84万 - 项目类别:
Mechanisms of Repair of the Alveolar Epithelium after Lung Injury
肺损伤后肺泡上皮的修复机制
- 批准号:
9898424 - 财政年份:2016
- 资助金额:
$ 89.84万 - 项目类别:
Mechanisms of Repair of the Alveolar Epithelium after Lung Injury
肺损伤后肺泡上皮的修复机制
- 批准号:
9247828 - 财政年份:2016
- 资助金额:
$ 89.84万 - 项目类别:
Mechanisms of alveolar epithelial repair in lung injury
肺损伤中肺泡上皮修复机制
- 批准号:
9130419 - 财政年份:2015
- 资助金额:
$ 89.84万 - 项目类别:
Role of Beta-catenin in Epithelial Repair in Acute Lung Injury
β-连环蛋白在急性肺损伤上皮修复中的作用
- 批准号:
7953459 - 财政年份:2010
- 资助金额:
$ 89.84万 - 项目类别:
Role of Beta-catenin in Epithelial Repair in Acute Lung Injury
β-连环蛋白在急性肺损伤上皮修复中的作用
- 批准号:
8286942 - 财政年份:2010
- 资助金额:
$ 89.84万 - 项目类别:
Role of Beta-catenin in Epithelial Repair in Acute Lung Injury
β-连环蛋白在急性肺损伤上皮修复中的作用
- 批准号:
8120783 - 财政年份:2010
- 资助金额:
$ 89.84万 - 项目类别:
Role of Beta-catenin in Epithelial Repair in Acute Lung Injury
β-连环蛋白在急性肺损伤上皮修复中的作用
- 批准号:
8496866 - 财政年份:2010
- 资助金额:
$ 89.84万 - 项目类别:
相似海外基金
The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome
肺泡单核吞噬细胞在急性呼吸窘迫综合征中的作用
- 批准号:
10470157 - 财政年份:2019
- 资助金额:
$ 89.84万 - 项目类别:
The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome
肺泡单核吞噬细胞在急性呼吸窘迫综合征中的作用
- 批准号:
10686310 - 财政年份:2019
- 资助金额:
$ 89.84万 - 项目类别:
K+ channels as key targets to favor alveolar epithelial integrity and function during the resolution of acute respiratory distress syndrome
K 通道是缓解急性呼吸窘迫综合征期间促进肺泡上皮完整性和功能的关键靶点
- 批准号:
402473 - 财政年份:2019
- 资助金额:
$ 89.84万 - 项目类别:
Operating Grants
The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome
肺泡单核吞噬细胞在急性呼吸窘迫综合征中的作用
- 批准号:
10231127 - 财政年份:2019
- 资助金额:
$ 89.84万 - 项目类别:
The Role of Alveolar Mononuclear Phagocytes in Acute Respiratory Distress Syndrome
肺泡单核吞噬细胞在急性呼吸窘迫综合征中的作用
- 批准号:
10002267 - 财政年份:2019
- 资助金额:
$ 89.84万 - 项目类别:
Influence of Acute Respiratory Distress Syndrome on Human Alveolar Macrophage Polarity
急性呼吸窘迫综合征对人肺泡巨噬细胞极性的影响
- 批准号:
9393863 - 财政年份:2018
- 资助金额:
$ 89.84万 - 项目类别:
Heterogeneous lung surfactant morphologies: effect on alveolar dynamics, and role in promoting acute respiratory distress syndrome
异质肺表面活性剂形态:对肺泡动力学的影响以及促进急性呼吸窘迫综合征的作用
- 批准号:
9406343 - 财政年份:2017
- 资助金额:
$ 89.84万 - 项目类别:
Cigarette smoke and the acute respiratory distress syndrome: mechanisms and the role of alveolar macrophages in priming
香烟烟雾与急性呼吸窘迫综合征:肺泡巨噬细胞在启动中的机制和作用
- 批准号:
9294401 - 财政年份:2017
- 资助金额:
$ 89.84万 - 项目类别:
Heterogeneous lung surfactant morphologies: effect on alveolar dynamics, and role in promoting acute respiratory distress syndrome
异质肺表面活性剂形态:对肺泡动力学的影响以及促进急性呼吸窘迫综合征的作用
- 批准号:
9219006 - 财政年份:2017
- 资助金额:
$ 89.84万 - 项目类别:
K+ channels as key targets to favor alveolar epithelial integrity and function during the resolution of acute respiratory distress syndrome
K 通道是缓解急性呼吸窘迫综合征期间促进肺泡上皮完整性和功能的关键靶点
- 批准号:
366631 - 财政年份:2016
- 资助金额:
$ 89.84万 - 项目类别:
Operating Grants














{{item.name}}会员




